REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers
S. Merrick, M. Nankivell, Matteo Quartagno, C. Clarke +16 more
2022Contemporary Clinical Trials18 citations Open access
Semantic Scholar

